Researchers and aid groups have stepped up to contain the disease and prevent future outbreaks.
The innovative approach from the Disney lab applies “click chemistry” to developing a treatment for a form of muscular dystrophy—and potentially a host of other conditions.
In addition to laboratory studies, the research from the Sanna and Roberto labs confirms the presence of the genetic variation in an alcohol-dependent patient population.
Findings from the Pipkin lab could help accelerate laboratory research and the development of potential therapeutics, including vaccines.